ENZO BIOCHEM INC
- CIK: 0000316253
- EIN: 13-2866202
- Business address: 60 EXECUTIVE BLVD, FARMINGDALE, New York, 11735
About ENZO BIOCHEM INC
ENZO BIOCHEM INC (CIK: 0000316253) is an American company incorporated in the state of New York. Head office is located at 60 EXECUTIVE BLVD, FARMINGDALE, New York, 11735. Work in the industry 8071 - (CF Office: Office of Life Sciences) SERVICES-MEDICAL LABORATORIES. ENZO BIOCHEM INC is a public company and trade via Over-The-Counter (OTC).Ownership
| Owner | Filings | Transaction Date | Type of Owner |
|---|---|---|---|
| Eckert Patricia | 0001952777 | Nov-15-2022 | officer: Interim CFO |
| Wolf James G. | 0001419248 | Oct-28-2022 | 10 percent owner |
| Cannon Kara | 0001913009 | Mar-24-2022 | officer: Chief Operating Officer |
| Radoff Bradley Louis | 0001380585 | Jan-03-2022 | director |
| Erfanian Hamid | 0001893172 | Nov-08-2021 | officer: Chief Executive Officer |
| Walters Ian B. | 0001834415 | Nov-25-2020 | director |
| TAGLIAFERRI MARY | 0001323304 | Nov-17-2020 | director |
| CLEMENS PETER J IV | 0001199421 | Feb-12-2020 | 10 percent owner |
| Fischer Rebecca J. | 0001798758 | Dec-30-2019 | director |
| Bench David | 0001797876 | Dec-23-2019 | officer: CHIEF FINANCIAL OFFICER |
| BLANK FABIAN | 0001788939 | Sep-17-2019 | 10 percent owner, other: See Remarks |
| HARBERT RAYMOND J | 0001233571 | May-20-2019 | 10 percent owner |
| HARBERT MANAGEMENT CORP | 0001259933 | May-20-2019 | 10 percent owner |
| HARBERT FUND ADVISORS, INC. | 0001616659 | May-20-2019 | 10 percent owner |
| Harbert Discovery Fund, LP | 0001626127 | May-20-2019 | 10 percent owner |
| BRYANT JOHN F. | 0001642336 | May-20-2019 | 10 percent owner |
| LUCAS KENAN | 0001642389 | May-20-2019 | 10 percent owner |
| HARBERT DISCOVERY FUND GP, LLC | 0001642538 | May-20-2019 | 10 percent owner |
| HARBERT DISCOVERY CO-INVESTMENT FUND I, LP | 0001771491 | May-20-2019 | 10 percent owner |
| HARBERT DISCOVERY CO-INVESTMENT FUND I GP, LLC | 0001771499 | May-20-2019 | 10 percent owner |
| Hanna Bruce A. | 0001694674 | Jan-05-2017 | director |
| O'Brien James Michael | 0001632111 | Mar-14-2016 | officer: SVP of Finance |
| Perlysky Dov | 0001072922 | Jan-06-2016 | director |
| BORTZ GREGORY M. | 0001483164 | Jan-06-2016 | director |
| KASTEN BERNARD L | 0001244745 | Oct-23-2014 | director |
| Whiteley Andrew P | 0001520777 | Jun-02-2011 | officer: VP BusDev-COO Enzo Lif Sci Inc |
| KRENITSKY KEVIN | 0001457809 | Mar-02-2009 | officer: President, Enzo Clinical Labs |
| FISCHETTE CHRISTINE | 0001423674 | Jan-03-2008 | officer: President, Enzo Therapeutics |
| Kent Stephen B H | 0001387811 | Jan-23-2007 | director |
| BALEZENTIS CARL W | 0001286811 | Jun-05-2006 | officer: Pres., Enzo Life Sciences, Inc |
| Crescenzo Andrew R. | 0001363902 | May-18-2006 | officer: Senior Vice President Finance |
| Conant Marcus | 0001296374 | Jul-15-2004 | director |
| WARSHAWSKY STANFORD S | 0001274817 | May-03-2004 | other: 01/2004, Resigned as Director |
| RABBANI SHAHRAM K | 0000901501 | Mar-08-2004 | director, officer: COO, Treasurer & Secretary |
| WEINER BARRY W | 0000901503 | Mar-08-2004 | director, officer: President and Director |
| RABBANI ELAZAR | 0000903568 | Mar-08-2004 | director, officer: Chairman of the Board and CEO |
| THALENFELD BARBARA E | 0001236358 | Mar-08-2004 | officer: VP Corporate Development |
| GOLDBERG DAVID C | 0001251336 | Mar-08-2004 | officer: VP, Business Development |
| KELKER NORMAN E | 0001251895 | Mar-08-2004 | officer: Senior Vice President |
| ENGELHARDT DEAN | 0001263101 | Mar-08-2004 | officer: Executive Vice President |
| BASS HERBERT B | 0001283546 | Mar-08-2004 | officer: Vice President, Finance |
| GERSON IRWIN | 0001181974 | Jan-15-2004 | director |
| LAZAR MELVIN F | 0001218403 | Jan-15-2004 | director |
| DELUCCA JOHN | 0001263102 | Jan-15-2004 | director |
| SIAS JOHN B | 0001263104 | Jan-15-2004 | director |
Stock Chart
Coming soon!
Jobs
Coming soon!
Recent SEC Filings
Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by ENZO BIOCHEM INC
| Filings | Format | Description | Filed/Effective | File/Film Number |
|---|---|---|---|---|
| 8-K | Document | Current report filing Acc-no: 0001013762-25-000595 (34 Act) Size: KB |
Mar-18-2025 | 25748498 |
| 10-Q | Document | Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001213900-25-024550 (34 Act) Size: KB |
Mar-17-2025 | 25744607 |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001213900-25-004656 ( Act) Size: 0 KB |
Jan-17-2025 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001213900-25-004655 ( Act) Size: 0 KB |
Jan-17-2025 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001213900-25-004653 ( Act) Size: 0 KB |
Jan-17-2025 | |
| 8-K | Document | Current report filing Acc-no: 0001213900-25-004240 (34 Act) Size: KB |
Jan-16-2025 | 25536158 |
| 8-K | Document | Current report filing Acc-no: 0001213900-25-003861 (34 Act) Size: KB |
Jan-15-2025 | 25533295 |
| 8-K | Document | Current report filing Acc-no: 0001213900-25-003421 (34 Act) Size: KB |
Jan-14-2025 | 25529553 |
| 10-Q | Document | Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001213900-24-109311 (34 Act) Size: KB |
Dec-16-2024 | 241551998 |
| 3 | Document | Initial statement of beneficial ownership of securities Acc-no: 0001213900-24-104564 ( Act) Size: 0 KB |
Dec-02-2024 | |
| ARS | Document | Annual report to security holders Acc-no: 0001140361-24-048044 (34 Act) Size: KB |
Nov-29-2024 | 241514803 |
| DEF 14A | Document | Definitive proxy statements Acc-no: 0001213900-24-103467 (34 Act) Size: KB |
Nov-27-2024 | 241511369 |
| 8-K | Document | Current report filing Acc-no: 0001213900-24-102169 (34 Act) Size: KB |
Nov-25-2024 | 241496088 |
| 8-K | Document | Current report filing Acc-no: 0001213900-24-091895 (34 Act) Size: KB |
Oct-30-2024 | 241407100 |
| 10-K | Document | Annual report pursuant to section 13 and 15(d) Acc-no: 0001213900-24-091798 (34 Act) Size: KB |
Oct-29-2024 | 241406556 |
| 8-K | Document | Current report filing Acc-no: 0001213900-24-081479 (34 Act) Size: KB |
Sep-24-2024 | 241320898 |
| 8-K | Document | Current report filing Acc-no: 0001213900-24-069031 (34 Act) Size: KB |
Aug-14-2024 | 241208009 |
| 8-K | Document | Current report filing Acc-no: 0001213900-24-064752 (34 Act) Size: KB |
Aug-02-2024 | 241171164 |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001013762-24-001213 ( Act) Size: 0 KB |
Jul-25-2024 | |
| 8-K | Document | Current report filing Acc-no: 0001013762-24-001207 (34 Act) Size: KB |
Jul-25-2024 | 241142938 |
Recent 20 filings. View all ENZO BIOCHEM INC filings
Reviews
Jean Bishop
Very good communication and delivery made within the timeframe I was advised of
Catherine
Thanks I look forward to using the product to improve my skin tone
Ryan Storey
Huge help thank you for your help .. y'all make it so much easier
Frequently Asked Questions
Tags:
- ENZO BIOCHEM INC overview
- ENZO BIOCHEM INC job
- ENZO BIOCHEM INC stock
- ENZO BIOCHEM INC ownership
- ENZO BIOCHEM INC CEO
- ENZO BIOCHEM INC documents
Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.
Orther Companies
Lumexa Imaging Holdings, Inc.
Update: Nov 18, 2025
BillionToOne, Inc.
Update: Oct 08, 2025
Caris Life Sciences, Inc.
Update: May 24, 2025
GenEmbryomics Ltd
Update: Feb 21, 2025
Advanced Biomed Inc.
Update: May 23, 2023
Fortrea Holdings Inc.
Update: May 16, 2023
Latest News
SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate...
Charter Communications to Pay $25 Million Penalty for Unauthorized...
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries...
SEC Charges Royal Bank of Canada with Internal Accounting Controls...
SEC Charges President/CCO of Prophecy Asset Management Advisory...
SEC Adopts Rules for the Registration and Regulation of Security-Based...
SEC Charges Crypto Company SafeMoon and its Executive Team for...
© 2022 